Wep Clinical Ireland
Wep Clinical Ireland is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
Open-Label Extension Study to Provide Continued Access to Avutometinib in Combination with Defactinib in Patients with Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)
Sponsor Verastem Inc.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Open-Label Extension Study to Provide Access to ATH434 in Patients with Multiple System Atrophy
Sponsor Alterity Therapeutics Limited
- Start (EU)
- Latest update
- Estimated end
- Not reported
An Open-Label Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of a Single Dose of ANX005 in Participants With Guillain-Barré Syndrome
Sponsor Annexon Inc.
- Start (EU)
- Latest update
- Estimated end
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy and Safety of RZ358 in Patients with Congenital Hyperinsulinism
Sponsor Rezolute Inc.
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Wep Clinical Ireland?
The 2026-10-09 snapshot links Wep Clinical Ireland to 4 distinct CTIS trials. Recorded services include Clinical monitoring, Data management, Project management, Medical expertise, among 9 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Wep Clinical Ireland?
The most frequently recorded therapeutic areas are Gynecology, Neurology, Solid Tumor Oncology. Recorded phases include Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Wep Clinical Ireland conducted?
The linked trials record locations in 6 countries, including France, Denmark, Spain, Bulgaria, Germany. These are trial locations, not confirmed office locations or countries where Wep Clinical Ireland delivered services.
What can this page tell me about Wep Clinical Ireland's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Wep Clinical Ireland. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Wep Clinical Ireland Limited